Global Crude Heparin Supply, Demand and Key Producers, 2023-2029

Global Crude Heparin Supply, Demand and Key Producers, 2023-2029

The global Crude Heparin market size is expected to reach $ 5318.6 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

This report studies the global Crude Heparin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Crude Heparin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Crude Heparin that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Crude Heparin total production and demand, 2018-2029, (Tons)

Global Crude Heparin total production value, 2018-2029, (USD Million)

Global Crude Heparin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Crude Heparin consumption by region & country, CAGR, 2018-2029 & (Tons)

U.S. VS China: Crude Heparin domestic production, consumption, key domestic manufacturers and share

Global Crude Heparin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)

Global Crude Heparin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Crude Heparin production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).

This reports profiles key players in the global Crude Heparin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Crude Heparin market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Crude Heparin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Crude Heparin Market, Segmentation by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others

Global Crude Heparin Market, Segmentation by Application
UFH
LMWH

Companies Profiled:
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

Key Questions Answered

1. How big is the global Crude Heparin market?

2. What is the demand of the global Crude Heparin market?

3. What is the year over year growth of the global Crude Heparin market?

4. What is the production and production value of the global Crude Heparin market?

5. Who are the key producers in the global Crude Heparin market?

6. What are the growth factors driving the market demand?